Clinical TrialsSearch results
Number of results: 334
Recruiting
- CAMBRIA-2: A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) vs Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) as Adjuvant Treatment for Patients With ER+/HER2- Early Breast Cancer and an Intermediate-High or High Risk of Recurrence Who Have Completed Definitive Locoregional Treatment and Have No Evidence of Disease
- Breast Cancer, Early Breast Cancer
- Hibi Kazushige
- 2023-11-11
Other
- A randomized controlled study comparing Anastrozole+TS-1 as postoperative chemotherapy in ER positive metastatic breast cancer
- Breast Cancer
- Department of Breast and Thyroid Surgery, Kawasaki Medical School
- 2007-08-12
Other
- biomarker study of the effect and adverse event for neoadjuvantchemotherapy with breast cancer patinets
- breast cancer
- national cancer center
- 2009-08-11
Other
- gene profiling study for the efficacy of Trastuzumab
- breast cancer
- National Cancer Center
- 2009-08-11
Other
- Phase II study of neoadjuvant treatment with Exemestane for 24 weeks in postmenopausal women with hormone receptor positive Stage II or IIIA breast cancer.
- Breast Cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2006-03-06
Other
- Randomized controlled trial comparing skin-moisturizing agents plus pyridoxine hydrochloride with skin-moisturizing agents alone to prevent hand-foot syndrome in patients received chemotherapy of capecitabine.
- Breast Cancer
- Shikoku Cancer Center
- 2009-06-16
Other
- Randomized Phase II Study of Neoadjuvant Chemotherapy and Trastuzumab (Herceptin) for Operable Breast Cancer with Overexpression of HER2
- Breast Cancer
- Office for cordination of Herceptin trial
- 2007-03-23
Not yet recruiting
- Development of walking exercise program for fatigue management of breast cancer patient
- Breast Cancer
- Satoko Miyawaki
- 2014-02-26
Recruiting
- A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy
- Breast Cancer
- Inoguchi Akihiro
- 2022-06-09
Other
- Outcome Assessment using SF-36 v2 in Stroke Patient Study
- Brain infarction
- OASIS STUDY Research Group
- 2008-05-31